David Mulham compensation by year
USANA HEALTH SCIENCES Summary Compensation Table · all 6 fiscal years held| Component | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|---|
| Salary | $411,718 | $417,689 | $434,147 | $459,169 | $479,454 | $458,830 |
| Bonus | $20,124 | $0 | $0 | $0 | $0 | $0 |
| Stock awards | $351,011 | $397,525 | $707,966 | $544,241 | $571,369 | $579,578 |
| Option awards | $0 | $0 | $0 | $0 | $0 | $0 |
| Non-equity incentive | $148,990 | $251,951 | $168,711 | $262,995 | $266,242 | $67,242 |
| Pension and deferred compensation | $0 | $0 | $0 | $0 | $0 | $0 |
| All other | $64,924 | $89,939 | $76,030 | $71,026 | $82,827 | $75,649 |
| Total | $996,688 | $1,157,103 | $1,386,854 | $1,337,431 | $1,399,893 | $1,181,299 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: USANA HEALTH SCIENCES INC DEF 14A filed March 31, 2023, accession 0001140361-23-015363, and prior-year filings.
How this page was built: the USANA HEALTH SCIENCES INC filed document, accession 0001140361-23-015363. Every figure is read from that document and cited to the page and table it appears in. Filed March 31, 2023.
Equity holdings
unvested awards at FY2022 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| RSU | 6,226 | $331,223 | — |
| RSU | 5,030 | $267,596 | — |
| RSU | 2,159 | $114,859 | — |
| RSU | 1,138 | $60,542 | — |
| Option | 7,709 | — | $63.02 |
Per the Outstanding Equity Awards at Fiscal Year-End table in USANA HEALTH SCIENCES INC's FY2022 proxy; value at the fiscal year-end close, as the company printed it.
Insider transactions since the last proxy
22 Form 4 lines since the FY2022 proxy (filed March 31, 2023)current to 2026-11-21 · updated nightly
| Date | Transaction | Plan | Shares | Price | Held after |
|---|---|---|---|---|---|
| 2025-12-10 | Sale | — | 873 | $21.00 | 8,387 |
| 2025-07-30 | Sale | — | 3,515 | $30.26 | 9,260 |
| 2025-03-10 | Sale | — | 3,234 | $32.98 | 12,775 |
| 2025-02-27 | Grant or award derivative | — | 18,641 | $0.00 | 32,671 |
| 2025-02-08 | Exercise or conversion | — | 1,677 | — | 13,436 |
| 2025-02-08 | Exercise or conversion | — | 2,573 | — | 16,009 |
| 2025-02-08 | Exercise or conversion derivative | — | 1,677 | $0.00 | 16,603 |
| 2025-02-08 | Exercise or conversion derivative | — | 2,573 | $0.00 | 14,030 |
The 8 most recent of 22 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →
USANA HEALTH SCIENCES’s named executive officers, FY2022
as the company reported each| Named executive officer | Role | FY2022 total |
|---|---|---|
| Kevin Guest | Chief Executive Officer & Chairman of the Board | $3,745,259 |
| Jim Brown | President | $1,793,141 |
| G. Douglas Hekking | Chief Financial Officer | $1,479,728 |
| Walter Noot | Chief Operating Officer | $1,259,621 |
| David Mulham · this page | Chief Sales Officer | $1,181,299 |
| Daniel Macuga Jr. | Chief Communications & Marketing Officer | $1,160,129 |
| Joshua Foukas | Chief Legal Officer & General Counsel | $1,154,997 |
The full USANA HEALTH SCIENCES compensation record
free company briefThis page is one person within USANA HEALTH SCIENCES's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the USANA HEALTH SCIENCES proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are USANA HEALTH SCIENCES's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.